Here we confirmed Smad2 was activated (phosphorylated) by TGF-β1 in a time-dependent manner and the up-regulation of P-Smad2 was reduced in rosiglitazone-treated ADPKD cyst lining epithelial cells. Here, SMAD2 is linked to autosomal dominant polycystic kidney disease.